InterStim XTM system Recharge-free neurostimulator for bowel and bladder control
The next generation of the first and most proven sacral neuromodulation system.
Download the brochure
Overview
Powerful
- Recharge-free system with over a decade of battery life* and up to 15 years under low energy settings†
- Proprietary fifth generation battery chemistry manufactured exclusively by Medtronic
- Memory storage on the neurostimulator allows patients and clinicians the flexibility to switch smart programmers without losing access to therapy settings and stored programs
- Detailed programmer display provides clearly visible information to confidently manage patient therapy
Personalized
- Seven distinct programs and four custom options with the smart programmer
- More features and flexibility to tailor patient therapy with our smart programmer‡
Proven
- Only InterStimTM systems are backed by:
90+
clinical
trials
350,000+
patients
treated
25
years SNM
experience
70+
FDA
approvals
The most common adverse events experienced during clinical studies include pain at implant sites, new pain, lead migration, infection, technical or device problems, adverse change in bowel or voiding function, and undesirable stimulation or sensations. Any of these may require additional surgery or cause return of symptoms.
Model specifications
|
Model |
97800 |
|---|---|
|
Battery type |
Recharge-free |
|
Weight |
22 g |
|
Height |
44 mm |
|
Length |
51 mm |
|
System components |
|
*
Under expected therapy settings and telemetry use.
†
Please see system eligibility, battery longevity, specifications manual for battery longevity estimates.
‡
Compared to patient fob.
Most proven claim supported by the following:
1
Siegel S, Noblett K, Mangel J, et al. Five-year follow-up results of a prospective, multicenter study of patients with overactive bladder treated with sacral neuromodulation. The Journal of Urology 2018, 229 -236.
2
Medtronic InterStim Therapy Clinical Summary (2018).
3
Hull T, Giese C, Wexner SD, et al. Long-term durability of sacral nerve stimulation therapy for chronic fecal incontinence. Dis Colon Rectum. 2013;56(2):23.